µÏÍþ¹ú¼Ê

µÏÍþÖƵÏÍþ¹ú¼Ê µÏÍþÖƵÏÍþ¹ú¼Ê

¼ò ¤™
  • ¼ò
  • ·±
  • EN
¤œ
Ïà¹ØÁ´½Ó
  • ½­ËÕºÀÉ­µÏÍþ¹ú¼ÊÒµ¼¯ÍÅÓÐÏÞ¹«Ë¾¥Y
ÐÂÎÅ·¢²¼
Press Release
Ê×Ò³  >  ÐÂÎÅÖÐÐÄ  >  ÐÂÎÅ·¢²¼
µÏÍþÖƵÏÍþ¹ú¼Ê£üHS-20093ÔÙ»ñNMPAÄÉÈëÍ»ÆÆÐÔÖÎÁƵÏÍþ¹ú¼ÊÎÓÃÓÚ¹ÇÈâÁöÖÎÁÆ
·¢²¼ÈÕÆÚ£º2025/02/25
×ÖºÅ

2025Äê2ÔÂ25ÈÕ£¬µÏÍþÖƵÏÍþ¹ú¼Ê¼¯ÍÅÓÐÏÞ¹«Ë¾£¨ÒÔϼò³Æ¡°µÏÍþÖƵÏÍþ¹ú¼Ê¡±£¬03692.HK£©Ðû²¼£¬¹«Ë¾×ÔÖ÷Ñз¢µÄB7-H3°ÐÏò¿¹Ìå-µÏÍþ¹ú¼ÊÎïżÁªÎADC£©×¢ÉäÓÃHS-20093£¨¸Ã²úÆ·£©»ñ¹ú¼ÒµÏÍþ¹ú¼ÊÆ·¼à¶½¹ÜÀí¾Ö£¨NMPA£©Åú×¼ÄÉÈë¡°Í»ÆÆÐÔÖÎÁƵÏÍþ¹ú¼ÊÎ£¬ÄⶨÊÊӦ֢ΪÖÎÁƾ­ÖÁÉÙ¶þÏßÖÎÁƺó½øÕ¹µÄ¹ÇÈâÁö»¼Õß¡£

±¾´ÎHS-20093ÔÙ»ñNMPAÄÉÈë¡°Í»ÆÆÐÔÖÎÁƵÏÍþ¹ú¼ÊÎµÃµ½Á˵ÏÍþÖƵÏÍþ¹ú¼ÊÕýÔÚÍƽøµÄARTEMIS-002Ñо¿Êý¾ÝµÄÖ§³Ö¡£ÕâÊÇÒ»ÏîÕýÔÚ½øÐеĢòÆÚ¡¢¿ª·Å±êÇ©¡¢Ëæ»ú¡¢¶àÖÐÐÄÁÙ´²ÊÔÑ飬ÆÀ¹ÀHS-20093ÔÚ¸´·¢»òÄÑÖÎÐÔ¹ÇÈâÁö¼°ÆäËû²»¿ÉÇгýµÄ¹ÇºÍÈí×éÖ¯ÈâÁö»¼ÕßÖеÄÓÐЧÐԺͰ²È«ÐÔ¡£ARTEMIS-002µÄ½á¹ûÒÑÔÚ2024ÄêÃÀ¹úÁÙ´²Ö×Áöѧ»á£¨ASCO£©Äê»áÉÏ×÷¿ÚÍ·±¨¸æչʾ¡£

½ØÖÁÄ¿Ç°£¬µÏÍþÖƵÏÍþ¹ú¼Ê¼°ºÏ×÷·½GSKÒÑ·Ö±ðÍƶ¯HS-20093(ºÏ×÷·½´úÂëGSK'227)»ñµÃÖС¢ÃÀ¡¢Å·µÏÍþ¹ú¼ÊÆ·¼à¹Ü×¢²á»ú¹¹5ÏîÍ»ÆÆÐÔÁÆ·¨/ÓÅÏȵÏÍþ¹ú¼ÊÎïÈ϶¨¡£

   ÃÀ¹úFDA-Í»ÆÆÐÔÁÆ·¨

   2024Äê8Ô  ¹ã·ºÆÚСϸ°û·Î°©

   ÖйúNMPA-Í»ÆÆÐÔÖÎÁƵÏÍþ¹ú¼ÊÎï

   2024Äê11Ô ¹ã·ºÆÚСϸ°û·Î°©

    Å·ÖÞEMA-ÓÅÏȵÏÍþ¹ú¼ÊÎïÈ϶¨

   2024Äê12Ô ¹ã·ºÆÚСϸ°û·Î°©

   ÃÀ¹úFDA-Í»ÆÆÐÔÁÆ·¨ 

   2025Äê1Ô ¹ÇÈâÁö

   ÖйúNMPA-Í»ÆÆÐÔÖÎÁƵÏÍþ¹ú¼ÊÎï

    2025Äê2Ô ¹ÇÈâÁö


¹ØÓÚ¹ÇÈâÁö

¹ÇÈâÁöÊÇ×î³£¼ûµÄ¶ñÐÔ¹ÇÖ×Áö£¬Õ¼È«²¿¶ñÐÔ¹ÇÖ×ÁöµÄ35%£¬Òѱ»ÁÐÈ롶µÚ¶þÅúº±¼û²¡Ä¿Â¼¡·[1]¡£¹ÇÈâÁöÖÐλ·¢²¡ÄêÁäΪ20Ë꣬ÊǶùͯºÍÇàÉÙÄê×î³£¼ûµÄÔ­·¢ÐÔ¶ñÐÔ¹ÇÖ×Áö¡£´óÔ¼20-30%µÄ¾ÖÏÞÐÔ£¨·ÇתÒÆÐÔ£©¹ÇÈâÁö»¼ÕߺÍ80%µÄתÒÆÐÔ¹ÇÈâÁö»¼Õß»á½øÈë½øÕ¹ÆÚ£¨¸´·¢»òתÒÆ£©£¬¶ø½øÕ¹ÆÚ¹ÇÈâÁö»¼ÕßµÄ5ÄêÉú´æÂʽöÔ¼20%[2-3]¡£ÔÚÈ«Çò·¶Î§ÄÚ£¬½ÓÊÜÒ»Ïß»¯ÁƺóµÄ¸´·¢»òÄÑÖÎÐÔ¹ÇÈâÁö»¼ÕßµÄÖÎÁÆÑ¡ÔñÓÐÏÞ£¬È±ÉÙÃ÷È·µÄ±ê×¼ÖÎÁÆ [4-5]¡£¶ÔÓÚ¼ÈÍù¶þÏß¾­Öκó½øÕ¹µÄ¹ÇÈâÁö»¼Õߣ¬ÖÎÁÆÑ¡Ôñ¸üΪÓÐÏÞ£¬Ä¿Ç°ÉÐÎÞ»ñÅúµÄÖÎÁÆ·½·¨£¬´æÔÚ¾Þ´óδÂú×ãµÄÁÙ´²ÐèÇó¡£


¹ØÓÚHS-20093

HS-20093ÊÇÒ»ÖÖB7-H3°ÐÏòADC£¬ÓÉÈ«ÈËÔ´¿¹B7-H3µ¥¿¹ÓëÍØÆËÒ칹øÒÖÖƼÁ(TOPOi)ÓÐЧÔغɹ²¼ÛÁ¬½Ó¶ø³É£¬ÕýÓÚÖйú¿ªÕ¹ÓÃÓÚÖÎÁƷΰ©£¬ÈâÁö£¬Í·¾±°©ÒÔ¼°ÆäËûʵÌåÁöµÄ¶àÏîÁÙ´²Ñо¿£¬ÆäÖÐ×î¸ßÑо¿½×¶ÎΪÁÙ´²¢óÆÚ ¡£2023Äê12ÔÂ20ÈÕ£¬µÏÍþÖƵÏÍþ¹ú¼ÊÓëGSK¶©Á¢¶À¼ÒÐí¿ÉЭÒ飬ÊÚÓèGSKÈ«Çò¶ÀÕ¼Ðí¿É£¨²»º¬ÖйúÄڵء¢Ïã¸Û¡¢°ÄÃż°Ì¨Í壩£¬ÒÔ¿ª·¢¡¢Éú²ú¼°ÉÌÒµ»¯¸Ã²úÆ·¡£


¹ØÓÚµÏÍþÖƵÏÍþ¹ú¼Ê
µÏÍþÖƵÏÍþ¹ú¼ÊÊÇÖйúÁìÏȵĴ´ÐÂÇý¶¯ÐÍÖƵÏÍþ¹ú¼ÊÆóÒµ£¬ÒÔ¡¸³ÖÐø´´Ð£¬Ìá¸ßÈËÀàÉúÃüÖÊÁ¿¡¹ÎªÊ¹Ãü£¬Öصã¹Ø×¢¿¹Ö×Áö¡¢¿¹¸ÐȾ¡¢ÖÐÊàÉñ¾­ÏµÍ³¡¢´úл¼°×ÔÉíÃâÒßµÈÖØ´ó¼²²¡ÖÎÁÆÁìÓò¡£½ØÖÁÄ¿Ç°£¬¹«Ë¾ÒÑÉÏÊÐ7¿î´´ÐµÏÍþ¹ú¼Ê£¬ÐγÉÁ˷ḻµÄ²úÆ·¹ÜÏß¡£µÏÍþÖƵÏÍþ¹ú¼ÊÁ¬Ðø¶àÄêλ¾ÓÈ«ÇòÖƵÏÍþ¹ú¼ÊÆóÒµ°ÙÇ¿¡¢ÖйúÒ½µÏÍþ¹ú¼ÊÑз¢²úÆ·Ïß×î¼Ñ¹¤ÒµÆóҵǰ3Ç¿£¬Êǹú¼ÒÖصã¸ßм¼ÊõÆóÒµ¡¢¹ú¼Ò¼¼Êõ´´ÐÂʾ·¶ÆóÒµ¡£µÏÍþÖƵÏÍþ¹ú¼ÊÓÚ2019Äê6ÔÂÔÚÏã¸ÛÁª½»Ëù¹ÒÅÆÉÏÊУ¨¹ÉƱ´úÂ룺03692.HK£©¡£
¸ü¶àÐÅÏ¢Çë·ÃÎÊ£º/¡£

²Î¿¼ÎÄÏ×£º

1. Strauss SJ, Frezza AM, Abecassis N, et al. Bone sarcomas: ESMO-EURACAN-GENTURIS-ERN PaedCan Clinical Practice Guideline for diagnosis, treatment and follow-up. Ann Oncol. 2021;32(12):1520-1536.

2. Durfee RA, Mohammed M, Luu HH. Review of Osteosarcoma and Current Management. Rheumatol Ther. 2016 Dec;3(2):221-243. doi: 10.1007/s40744-016-0046-y. Epub 2016 Oct 19. PMID: 27761754; PMCID: PMC5127970.

3. Meltzer PS, Helman LJ. New Horizons in the Treatment of Osteosarcoma. N Engl J Med. 2021;385(22):2066-2076.

4. National Comprehensive Cancer Network (NCCN). NCCN clinical practice guidelines in oncology (NCCN Guidelines): bone cancer. August 20, 2024. Version 1.2025. Accessed 24 October 2024.https://www.nccn.org/professionals/physician_gls/pdf/bone.pdf

5.ÖйúÁÙ´²Ö×Áöѧ»á£¬¹ÇÓëÈí×éÖ¯Ö×ÁöÕïÁÆÖ¸ÄÏ£¨2024£©.

ÉùÃ÷£º
1¡¢±¾¹«¸æ½ö¹©Ò½ÁÆÎÀÉúרҵÈËÊ¿²ÎÔÄ£¬·Ç¹ã¸æÓÃ;¡£

2¡¢µÏÍþÖƵÏÍþ¹ú¼Ê²»ÍƼöÈκÎδ»ñÅúµÏÍþ¹ú¼ÊƷʹÓúÍ/»òδ»ñÅúÊÊÓ¦Ö¢ÓõÏÍþ¹ú¼Ê£¬Ò಻¶ÔÈκεÏÍþ¹ú¼ÊÆ·ºÍ/»òÊÊÓ¦Ö¢×÷ÍƼö¡£

3¡¢±¾¹«¸æÖÐÉæ¼°µÄÐÅÏ¢½ö¹©²Î¿¼£¬Çë×ñ´ÓÒ½Éú»òÆäËûÒ½ÁÆÎÀÉúרҵÈËÊ¿µÄÒâ¼û»òÖ¸µ¼¡£Ò½ÁÆÎÀÉúרҵÈËÊ¿×÷³öµÄÈκÎÓëÖÎÁÆÓйصľö¶¨Ó¦¸ù¾Ý»¼ÕߵľßÌåÇé¿ö²¢×ñÕÕµÏÍþ¹ú¼ÊƷ˵Ã÷Êé¡£

4¡¢ÈçÐèÁ˽⹫˾ÈκβúÆ·¡¢Ò½ÁÆ»ò¼²²¡µÄÏà¹ØÐÅÏ¢£¬ÇëÎñ±Ø×ÉѯҽÁÆÎÀÉúרҵÈËÊ¿¡£



Ç°Õ°ÐÔ˵Ã÷


±¾ÐÂΟåÖ¼ÔÚÌṩ¹ØÓÚµÏÍþÖƵÏÍþ¹ú¼Ê¼¯ÍÅÓÐÏÞ¹«Ë¾¼°Æ丽Êô¹«Ë¾£¨°üÀ¨Æä×Ó¹«Ë¾£¬Í³³ÆΪ¡°µÏÍþÖƵÏÍþ¹ú¼Ê¡±£©µÄÐÅÏ¢¡£Ëü²»¹¹³É¶ÔµÏÍþÖƵÏÍþ¹ú¼Ê»òÈκÎͶ×ʽ¨ÒéµÄÐÅÏ¢Åû¶¡£

±¾ÐÂΟå°üº¬µÄÐÅÏ¢¿ÉÄÜ°üÀ¨ÓëµÏÍþÖƵÏÍþ¹ú¼ÊÒµÎñºÍ²úÆ·Ç°¾°¡¢¼Æ»®¡¢ÐÅÄî¡¢Ô¤ÆںͲßÂÔÏà¹ØµÄÇ°Õ°ÐÔÉùÃ÷¡£ÕâЩÉùÃ÷ÊÇ»ùÓÚÍƲâÐÔ¼ÙÉèµÄÔ¤²â£¬²¢²»±£Ö¤Î´À´µÄ±íÏÖ¡£ËüÃÇÊܵ½ÖîÈç¿Æѧ¡¢ÉÌÒµ¡¢ÕþÖΡ¢¾­¼Ã¡¢²ÆÎñ¡¢·¨ÂÉÒòËØÒÔ¼°¾ºÕù»·¾³ºÍÉç»áÌõ¼þµÈ·çÏպͲ»È·¶¨ÐÔµÄÓ°Ï죬ÕâЩÒòËغܶ඼ÊǵÏÍþÖƵÏÍþ¹ú¼ÊÎÞ·¨¿ØÖÆÇÒÄÑÒÔÔ¤²âµÄ£¬Òò´Ëʵ¼Ê½á¹û¿ÉÄÜÓë´Ë´¦ËùÊöÓÐÏÔÖø²îÒ죬ÇÒ¹ýÈ¥µÄ֤ȯ¼Û¸ñÇ÷ÊƲ»Ó¦×÷ΪδÀ´ÐÐÇéµÄÖ¸µ¼¡£Òò´Ë£¬Í¶×ÊÕßÔÚʹÓÃÕâЩÐÅÏ¢½øÐÐͶ×ʾö²ßʱӦ½÷É÷ÐÐÊ¡£¡°ÖÂÁ¦ÓÚ¡±¡°Ô¤ÆÚ¡±¡°ÏàÐÅ¡±¡°Ô¤²â¡±¡°Òâͼ¡±¡°Ô¤¼Æ¡±¡°¿ÉÄÜ¡±¡°½«¡±¡°Ó¦¸Ã¡±¡°¼Æ»®¡±¡°¼ÌÐø¡±¡°Ä¿±ê¡±¡°¿¼ÂÇ¡±¡°¹À¼Æ¡±¡°Ö¸µ¼¡±¡°Ç±ÔÚ¡±¡°×·Çó¡±ÒÔ¼°ÓÚÈκÎδÀ´¼Æ»®¡¢Ðж¯»òʼþµÄÌÖÂÛÖÐʹÓõÄÀàËÆ´ÊÓïºÍÊõÓ¾ù±íʾǰհÐÔÉùÃ÷¡£

µÏÍþÖƵÏÍþ¹ú¼Ê²»³Ðŵ»ò±£Ö¤Ç°Õ°ÐÔÐÅÏ¢µÄ׼ȷÐÔ¡¢¼°Ê±ÐÔ»òÍêÕûÐÔ£¬²¢ÇÒ²»³Ðµ£¸üлòÐÞ¶©ÕâЩǰհÐÔÉùÃ÷µÄÒåÎñ¡£ÎÞÂÛÊǵÏÍþÖƵÏÍþ¹ú¼Ê»¹ÊÇÆäÈκζ­Ê¡¢Ô±¹¤»ò´úÀíÈË£¬¾ù²»¶ÔÈκÎÖ¤Ã÷²»×¼È·»òÎÞ·¨ÊµÏÖµÄÇ°Õ°ÐÔÉùÃ÷¸ºÔð£¬Ò²²»¶ÔÒòÒÀÀµ±¾ÐÂΟåÖÐÌṩµÄÐÅÏ¢¶ø²úÉúµÄÈκÎËðʧ»òË𺦸ºÔ𣬰üÀ¨µ«²»ÏÞÓÚÖ±½Ó¡¢Å¼È»¡¢¼ä½Ó»ò³Í·£ÐÔµÄË𺦡£


¡¾ÍøÕ¾µØͼ¡¿¡¾sitemap¡¿